Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine

Ceyhun, Gökhan

doi:10.5152/eurasianjmed.2022.22291

Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine

Gökhan CEYHUN (Atatürk Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Erzurum, Türkiye)

Eurasian Journal of Medicine

0 0

Yıl: 2022 Cilt: 54 Sayı: 1 Sayfa Aralığı: 43 - 46 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2022.22291 İndeks Tarihi: 24-05-2023

Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine

Öz:

Whether due to myocardial infarction or not, we find troponin levels to be high when myocardial damage occurs. Elevated troponin may not always be a myocardial infarction caused by plaque rupture on the basis of classically known coronary thrombosis. In this sense, infarction types have been defined. In this review, we aimed to bring together the conditions that may directly or indirectly affect the myocardium, except for acute coronary syndromes.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Garg P, Morris P, Fazlanie AL, et al. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med. 2017;12(2):147-155. [CrossRef]
2. Tamer AF, Bakirci EM, Habip EMRE, Karal H, Gündoğdu F, Keleş M. A case of scorpion sting which caused toxic Myocardit and acute heart failure. Meandros Med Dent J;12(2):41-43.
3. Aslan S, Uzkeser M, Seven B, et al. The evaluation of myocardial damage in 83 young adults with carbon monoxide poisoning in the east Anatolia region in Turkey. Hum Exp Toxicol. 2006;25(8):439- 446. [CrossRef]
4. Aslan S, Erol MK, Karcioglu O, Meral M, Cakir Z, Katirci Y. The investigation of ischemic myocardial damage in patients with carbon monoxide poisoning. Anadolu Kardiyol Derg. 2005;5(3): 189-193.
5. Bayramoglu A, Kocak AO, Akbas I, Unlu A. Reversible left bundle-branch block due to carbon monoxide poisoning: a case report. Am J Emerg Med. 2016;34(2):342.e1-342.e3. [CrossRef]
6. Doğruyol S, Akbaş I, Tekin E, Doğruyol MT. Carbon monoxide intoxication in geriatric patients: how important are lactate values at admission? Hum Exp Toxicol. 2020;39(6):848-854. [CrossRef]
7. Akin A, Bağci Z, Güler S, Arslan D. Troponin Yüksekliğine neden olan demir İntoksikasyonu: Ülkemizden Bildirilen İlk vaka. Selçuk Tıp Derg. 2020;36(2):143-146.
8. Sevindik M, Özdemir B, Braidy N, Akgül H, Akata İ, Selamoğlu Z. Potential cardiogenic effects of poisonous mushrooms. Mantar Derg. 2021;12(1):80-86.
9. O’Brien PJ. Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker. Expert Rev Mol Diagn. 2006;6(5):685- 702. [CrossRef]
10. Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229- 4361. [CrossRef]
11. Sorodoc V, Sirbu O, Lionte C, et al. The value of troponin as a biomarker of chemotherapyinduced cardiotoxicity. Life (Basel). 2022;12(8):1183. [CrossRef]
12. Isemede DA, Sharma A, Bailey J. Assessing the cardiotoxicity of epirubicin-based chemotherapy in patients with breast cancer using high-sensitivity cardiac troponin T, N-terminal pro b-type natriuretic peptide and soluble suppression of tumorigenicity-2. Ann Clin Biochem. 2022;59(6):410-419. [CrossRef]
13. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768-2801. [CrossRef]
14. Ozkanlar Y, Aktas MS, Turkeli M, et al. Effects of ramipril and darbepoetin on electromechanical activity of the heart in doxorubicin-induced cardiotoxicity. Int J Cardiol. 2014;173(3):519-521. [CrossRef]
15. Polk A, Vistisen K, Vaage-Nilsen M, Nielsen DL. A systematic review of the pathophysiology of 5-flu orour acil- induc ed cardiotoxicity. BMC Pharmacol Toxicol. 2014;15(1):47. [CrossRef]
16. Gelen V, Şengül E, Çınar DA. The effects of rutin and quercetin on ECG parameters in 5-FUinduced cardiotoxicity rat model. World J Adv Res Rev. 2021;9(3):253-257. [CrossRef]
17. Moslehi JJ. Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med. 2016;375(15):1457-1467. [CrossRef]
18. Yaşar H, Tanoglu C, Gulapoglu M, Suleyman H, Arslan Y. A study to reveal the effectiveness of taxifolin in sunitinib-induced oxidative muscle damage in rats. Arch Med Sci-Civil Dis. 2021;6(1):103-108.
19. Aldemir MN, Simsek M, Kara AV, et al. The effect of adenosine triphosphate on sunitinib-induced cardiac injury in rats. Hum Exp Toxicol. 2020;39(8):1046-1053. [CrossRef]
20. Erol MK, Erol S, Koruk M, Ertek M, Bozkurt E. Effects of interferon-α therapy on cardiac function in patients with chronic hepatitis B infection. Heart Vessels. 2004;19(6):263-266. [CrossRef]
21. Becit N, Ceviz M, Koçak H, et al. The effect of vascular endothelial growth factor on angiogenesis. An experimental study. Eur J Vasc Endovasc Surg. 2001;22(4):310-316. [CrossRef]
22. Abdel-Qadir H, Ethier JL, Lee DS, Thavendiranathan P, Amir E. Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: a systematic review and meta-analysis. Cancer Treat Rev. 2017;53:120-127. [CrossRef]
23. Salem JE, Manouchehri A, Bretagne M, et al. Cardiovascular toxicities associated with ibrutinib. J Am Coll Cardiol. 2019;74(13):1667-1678. [CrossRef]
24. Drobni ZD, Alvi RM, Taron J, et al. Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque. Circulation. 2020;142(24):2299-2311. [CrossRef]
25. Simsek M, Tekin SB, Bilici M. Immunological agents used in cancer treatment. Eurasian J Med. 2019;51(1):90-94. [CrossRef]
26. Pitini V, Arrigo C, Azzarello D, et al. Serum concentration of cardiac troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes. Blood. 2003;102(9):3456-3457. [CrossRef]
27. McCarthy LJ, Danielson CF, Skipworth EM, Peters SL, Miraglia CC, Antony AC. Myocardial infarction njury Is relatively common at presentation of acute thrombotic thrombocytopenic purpura: the Indiana University Experience. Ther Apher. 2002;6(1):2-4. [CrossRef]
28. Hassan MZO, Awadalla M, Tan TC, et al. Serial measurement of global longitudinal strain among women with breast cancer treated with proton radiation therapy: a prospective trial for 70 patients. Int J Radiat Oncol Biol Phys. 2022. [CrossRef]
29. Curtis CA, Yue Y, Mohammed T, Omari R, Lautenschlaeger T. A retrospective review of cardiac events pre-RT and post-RT in a lung cancer population. Int J Radiat Oncol Biol Phys. 2022;114(3):e410. [CrossRef]
30. Saritemur M, Akoz A, Kalkan K, Emet M. Intracranial hemorrhage with electrocardiographic abnormalities and troponin elevation. Am J Emerg Med. 2013;31(1):271.e5-271.e7. [CrossRef]
31. Ceylan M , Yalçın A. Non-kardiyak iskemik inmeli hastalarda prognoz ile troponin ilişkisi. Harran Univ Tıp Fak Derg. 2018;15(3):236-240.
32. Su YC, Huang KF, Yang FY, Lin SK. Elevation of troponin I in acute ischemic stroke. PeerJ. 2016;4:e1866. [CrossRef]
33. Jensen JK, Atar D, Mickley H. Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol. 2007;99(6):867-870. [CrossRef]
34. Feher G, Tibold A, Koltai K, Szapary L. The clinical importance of troponin elevation in ischaemic cerebrovascular events: a clinical review. Cardiol Ther. 2014;1(7):141-149.
35. Ermis E, Demirelli S, Ceylan M, et al. The evaluation of myocardial function of patients in the early stage of acute ischemic stroke by twodimensional speckle tracking echocardiography. J Clin Ultrasound. 2016;44(5):305-311. [CrossRef]
36. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788- 1830. [CrossRef]
37. Meyer T, Binder L, Hruska N, Luthe H, Buchwald AB. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol. 2000;36(5):1632-1636. [CrossRef]
38. Jiménez D, Uresandi F, Otero R, et al. Troponinbased risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. Chest. 2009;136(4):974- 982. [CrossRef]
39. Kerget B, Erol Afşin D, Aksakal A, et al. Could VEGF D level have a role in clinical risk scoring, estimation of thrombus burden, and treatment in acute pulmonary thromboembolism? Int J Clin Pract. 2021;75(10):e14601. [CrossRef]
40. Setsuta K, Kitahara Y, Arae M, Ohbayashi T, Seino Y, Mizuno K. Elevated cardiac troponin T predicts adverse outcomes in hypertensive patients. Int Heart J. 2011;52(3):164-169. [CrossRef]
41. Davison JM. Pre-eclampsia as a multi-system disease. Adv Exp Med Biol; 1989;252:119-131. [CrossRef]
42. Barton JR, Hiett AK, O’Connor WN, Nissen SE, Greene JW. Endomyocardial ultrastructural findings in preeclampsia. Am J Obstet Gynecol. 1991;165(2):389-391. [CrossRef]
43. Fleming SM, O’Gorman T, Finn J, Grimes H, Daly K, Morrison JJ. Cardiac troponin I in preeclampsia and gestational hypertension. BJOG. 2000;107(11):1417-1420. [CrossRef]
44. Ammann P, Fehr T, Minder EI, Günter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27(6):965-969. [CrossRef]
45. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054- 1062. [CrossRef]
46. Kesmez Can FK, Alay H, Albayrak A, et al. The effects of laboratory parameters on the prognosis of COVID-19. Eurasian J Med. 2022;54(3):242- 247. [CrossRef]
47. Kocak OF, Ozgeris FB, Parlak E, et al. Evaluation of serum trace element levels and biochemical parameters of COVID-19 patients according to disease severity. Biol Trace Elem Res. 2022;200(7):3138-3146. [CrossRef]
48. Davis GK, Labugger R, Van Eyk JE, Apple FS. Cardiac troponin T is not detected in Western blots of diseased renal tissue. Clin Chem. 2001;47(4):782-783. [CrossRef]
49. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PA, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem. 1998;44(9):1919-1924. [CrossRef]
50. Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 1995;41(12):1710- 1715. [CrossRef]
51. Haller C, Zehelein J, Remppis A, Müller-Bardorff M, Katus HA. Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin Chem. 1998;44(5):930-938. [CrossRef]
52. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a metaanalysis. Circulation. 2005;112(20):3088-3096. [CrossRef]
53. Ortega LM, Heung M. The use of cell cycle arrest biomarkers in the early detection of acute kidney injury. Is this the new renal troponin? Nefrologia. 2018;38(4):361-367. [CrossRef]
54. Goldstein SL. Acute kidney injury biomarkers: renal angina and the need for a renal troponin I. BMC Med. 2011;9(1):135. [CrossRef]
55. Emet M, Akoz A, Aslan S, Saritas A, Cakir Z, Acemoglu H. Assessment of cardiac injury in patients with blunt chest trauma. Eur J Trauma Emerg Surg. 2010;36(5):441-447. [CrossRef]
56. Ceyhun G. The relationship of the serum endocan level with the CHA 2 DS 2-VASc score in patients with paroxysmal atrial fibrillation. Egypt Heart J. 2021;73(1):9. [CrossRef]

APA	Ceyhun G (2022). Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. , 43 - 46. 10.5152/eurasianjmed.2022.22291
Chicago	Ceyhun Gökhan Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. (2022): 43 - 46. 10.5152/eurasianjmed.2022.22291
MLA	Ceyhun Gökhan Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. , 2022, ss.43 - 46. 10.5152/eurasianjmed.2022.22291
AMA	Ceyhun G Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. . 2022; 43 - 46. 10.5152/eurasianjmed.2022.22291
Vancouver	Ceyhun G Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. . 2022; 43 - 46. 10.5152/eurasianjmed.2022.22291
IEEE	Ceyhun G "Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine." , ss.43 - 46, 2022. 10.5152/eurasianjmed.2022.22291
ISNAD	Ceyhun, Gökhan. "Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine". (2022), 43-46. https://doi.org/10.5152/eurasianjmed.2022.22291

APA	Ceyhun G (2022). Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. Eurasian Journal of Medicine, 54(1), 43 - 46. 10.5152/eurasianjmed.2022.22291
Chicago	Ceyhun Gökhan Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. Eurasian Journal of Medicine 54, no.1 (2022): 43 - 46. 10.5152/eurasianjmed.2022.22291
MLA	Ceyhun Gökhan Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. Eurasian Journal of Medicine, vol.54, no.1, 2022, ss.43 - 46. 10.5152/eurasianjmed.2022.22291
AMA	Ceyhun G Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. Eurasian Journal of Medicine. 2022; 54(1): 43 - 46. 10.5152/eurasianjmed.2022.22291
Vancouver	Ceyhun G Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine. Eurasian Journal of Medicine. 2022; 54(1): 43 - 46. 10.5152/eurasianjmed.2022.22291
IEEE	Ceyhun G "Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine." Eurasian Journal of Medicine, 54, ss.43 - 46, 2022. 10.5152/eurasianjmed.2022.22291
ISNAD	Ceyhun, Gökhan. "Sensitive Marker Affected by All Systemic Abnor malit ies—t ropon ine". Eurasian Journal of Medicine 54/1 (2022), 43-46. https://doi.org/10.5152/eurasianjmed.2022.22291